Smith & Nephew Halts Sales Of Renasys Negative Pressure Wound Therapy
This article was originally published in The Gray Sheet
Executive Summary
FDA instructed to the company to obtain new clearances for design modifications already made to Renasys. The company says 510(k)s for these changes are pending.